Adherence to HIV antiretroviral therapy in HIV plus Ugandan patients purchasing therapy

被引:120
作者
Byakika-Tusiime, J
Oyugi, JH
Tumwikirize, WA
Katabira, ET
Mugyenyi, PN
Bangsberg, DR
机构
[1] Makerere Univ, Sch Med, Kampala, Uganda
[2] Acad Alliance AIDS Care & Prevent Africa, Kampala, Uganda
[3] UCSF, San Francisco Gen Hosp, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA
[4] UCSF, San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA USA
[5] Joint Clin Res Ctr, Kampala, Uganda
关键词
adherence; antiretroviral therapy; self-purchasing; sub-Saharan Africa;
D O I
10.1258/0956462052932548
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Our objective was to determine the level of adherence and reasons for non-adherence to antiretroviral therapy (ART) among HIV-positive (HIV+) people on ART in a resource-limited setting. Patients receiving ART were recruited into the cross-sectional study from three treatment centres in Kampala, Uganda. The number of missed doses over the last three days was assessed by structured patient interviews and dichotomized at +/-95% adherence. Reasons for non-adherence were assessed with both structured patient interviews and unstructured qualitative interviews. Independent predictors of non-adherence were assessed with multivariate logistic regression. In all, 304 HIV-infected persons on ART were enrolled into the study Factors associated with non-adherence were marital status (odds ratio (OR)= 2.93, 95% confidence interval (CI) 1.32-6.50) and low monthly income <50 US$ [OR= 2.77, 95% CI 1.64-4.67]. We concluded that levels of self-reported adherence in patients receiving ART in Kampala are comparable to levels in resource-rich settings with inability to purchase and secure a stable supply as a major barrier to adherence.
引用
收藏
页码:38 / 41
页数:4
相关论文
共 17 条
[1]
[Anonymous], 2002, REPORT GLOBAL HIVAID
[2]
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[3]
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[4]
Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil [J].
Brigido, LFM ;
Rodrigues, R ;
Casseb, J ;
Oliveira, D ;
Rossetti, M ;
Menezes, P ;
Duarte, AJS .
AIDS PATIENT CARE AND STDS, 2001, 15 (11) :587-593
[5]
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[6]
Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386
[7]
Preventing antiretroviral anarchy in sub-Saharan Africa [J].
Harries, AD ;
Nyangulu, DS ;
Hargreaves, NJ ;
Kaluwa, O ;
Salaniponi, FM .
LANCET, 2001, 358 (9279) :410-414
[8]
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response [J].
Haubrich, RH ;
Little, SJ ;
Currier, JS ;
Forthal, DN ;
Kemper, CA ;
Beall, GN ;
Johnson, D ;
Dubé, MP ;
Hwang, JY ;
McCutchan, JA .
AIDS, 1999, 13 (09) :1099-1107
[9]
Laurence J, 2001, NEW ENGL J MED, V345, P68
[10]
The Senegalese government's highly active antiretroviral therapy initiative:: an 18-month follow-up study [J].
Laurent, C ;
Diakhaté, N ;
Gueye, NFN ;
Touré, MA ;
Sow, PS ;
Faye, MA ;
Gueye, M ;
Lanièce, I ;
Kane, CT ;
Liégeois, F ;
Vergne, L ;
Mboup, S ;
Badiane, S ;
Ndoye, I ;
Delaporte, E .
AIDS, 2002, 16 (10) :1363-1370